Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 17.30
-0.27 (-1.54%)
At close: Feb 2, 2026
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 1.83B CNY in the quarter ending September 30, 2025, with 3.78% growth. This brings the company's revenue in the last twelve months to 6.01B, down -25.83% year-over-year. In the year 2024, Shijiazhuang Yiling Pharmaceutical had annual revenue of 6.51B, down -36.88%.
Revenue (ttm)
6.01B
Revenue Growth
-25.83%
P/S Ratio
4.81
Revenue / Employee
513.74K
Employees
11,708
Market Cap
28.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.51B | -3.81B | -36.88% |
| Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
| Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
| Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
| Dec 31, 2020 | 8.78B | 2.96B | 50.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humanwell Healthcare (Group) | 24.18B |
| Livzon Pharmaceutical Group | 11.85B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Dong-E-E-Jiao | 6.12B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 5.37B |
| Kangmei Pharmaceutical | 5.28B |
| Chengdu Kanghong Pharmaceutical Group | 4.67B |